Active — Not RecruitingNot Applicable

The Transitions Project: Efficacy Trial

United States100 participantsStarted 2021-09-30

Plain-language summary

The aim of this study is to evaluate the efficacy of a brief psychoeducational intervention to improve quality of life in patients with lung cancer who are transitioning from active treatment to surveillance.

Who can participate

Age range21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 21 or older * Able to read and respond in English * Diagnosis of non-small cell lung cancer or small cell lung cancer * Documented curative treatment plan including systemic therapy +/- radiation and +/- surgery * Completed cancer treatment within past 3 weeks * If final treatment is systemic therapy +/- radiation: within 3 weeks after cancer care team determination that treatment is complete * If final treatment is surgery: within 3 weeks after hospital discharge following surgery Exclusion Criteria: * Comorbid health condition that would interfere with study participation * Current participation in cognitive behavioral therapy treatment

What they're measuring

Quality of life: Functional Assessment of Cancer Therapy-Lung Cancer

Timeframe: Up to 12 weeks

Trial details

NCT IDNCT05087251

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-06-15

View on ClinicalTrials.gov More Lung Cancer trials